Asset sale Completed Sponsor buyer
GI Partners acquisition of CDMO and Cell Solutions businesses of Charles River Laboratories
Advisers
CDMO and Cell Solutions businesses of Charles River Laboratories
Target
Not disclosed
- Target
- CDMO and Cell Solutions businesses of Charles River Laboratories
- Acquirer
- GI Partners
- Seller
- Charles River Laboratories International
- Target based in
- United States (unverified)
- Buyer based in
- United States
- Seller based in
- United States
- Completed
- 7 May 2026
- Sector
- Pharma Services
- Tags
- Pharma Services, Cell Therapy, Contract Manufacturing
In the league tables
Similar deals
- Webster Equity Partners acquisition of Lifecore Biomedical Sep 2026 · US$664m · Pharma Services
- Kincell Bio and Cellipont Bioservices merger Sep 2026 · Pharma Services
- NueCell Bio acquisition of assets, business operations and customer relationships Aug 2026 · Pharma Services
- Samsung Biologics Co. acquisition of PolyPeptide Group AG Jul 2026 · US$1.5bn · Pharma Services
- Apax Partners acquisition of Gerresheimer global Primary Packaging Plastics business Jul 2026 · US$1.7bn · Packaging
